InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by BRADSHER NEAL C, Director. Director active across 1 companies, notably Lineage Cell Therapeutics, Inc.. Cumulatively, 2 reports have been published. The latest transaction was filed on 25 June 2021 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Declarations2 total
€45,58524,720 shares@ €1.844100.0% of flow
Common Shares
SEC:0000919574-21-004286·
€45,58524,720 shares@ €1.8440.011% mcap50.0% of flow
Common Shares
SEC:0000919574-21-004286:0·
2 of 2 declarations
About BRADSHER NEAL C
Neal C. Bradsher is a Board Member at Lineage Cell Therapeutics, Inc. He participates in overseeing the company's activities and strategic decision-making. His experience in the biopharmaceutical sector allows him to make significant contributions to the board.
